New Day Diagnostics Logo
  • Home
  • ColoHealth
    • Patient Information
    • Physician Information
  • CLIA Laboratory
  • Products
    • Colorectal Cancer
    • AxSpA
      • Patient Information
      • Physician Information
    • Celiac
    • H. pylori
    • Covid-Flu-RSV
    • COVID-19
    • Oncology Product Pipeline
      • ColoPlex Plus
      • Procare
  • About Us
    • Our Team
    • News
    • For Media

CA11-19 Monitoring data presented at Gastrointestinal Cancer Symposia (Poster)

by Jessica Etheridge | Jan 22, 2016 | Products & Pipeline, Research & Development

The goal of this study was to analyze case study data that suggests the value of adding CA11-19 to monitoring patients at risk of recurrence of colorectal cancer. Download The...

CA 11-19: A Tumor Marker to Detect Colorectal Cancer (Poster)

by Jessica Etheridge | Jul 10, 2015 | Products & Pipeline, Research & Development

The primary objective of this study was to determine the correlation between elevated levels of the CA 11-19 tumor marker in blood and the presence of colorectal cancer or pre-cancer. Download the Study

Colon cancer test developed in Knoxville gets approval overseas

by Jessica Etheridge | Oct 14, 2014 | Products & Pipeline

Full Story at WVLT Local 8 KNOXVILLE, Tenn. (WVLT) — It’s a top killer: colon cancer. So far, a colonoscopy has been the number one way to detect it. But something developed in Knoxville may soon change that. It’s nothing for Jack Smith to roll up a...

January 13th, 2014 – Passion, perseverance behind the development of ColoMarker

by Jessica Etheridge | Jan 14, 2014 | Products & Pipeline, Research & Development

Passion, perseverance behind the development of ColoMarker® Knox Focus At 75 years old, Tommye Jordan is a quick witted, energetic grandmother; dressed unassumingly in a festive holiday sweater…. She is also responsible for ColoMarker®- a groundbreaking medical...
Next Entries »

Topics

  • Articles
  • Company Details
  • News and Events
  • Products & Pipeline
  • Research & Development
  • Uncategorized

Recent Posts

  • Press Release: ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening–Now Direct-to-Consumer
  • Hepion Pharmaceuticals, New Day Diagnostics execute binding letter of intent
  • Press Release: Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC
  • We’ve Been Busy, and the Press Has Noticed!
  • Knoxville lab launches blood test for colorectal cancer screening across US: ‘Life mission’

New Day Diagnostics Home

ColoHealth Home

Call Us: 865-299-6250
Email Us: [email protected]

Legal

Privacy

E-Library

BSI Medical Device Quality Assurance Mark
clia logo

CLIA#: 44D2184836

  • Follow
  • Follow
Knoxville Chamber of Commerce Member

Copyright © 2012-2024. All Rights Reserved.
Web Site usage is subject to New Day Diagnostics / EDP Biotech’s Web Site Usage and Privacy Policy. Copyright ©2024 New Day Diagnostics, All Rights Reserved. All other copyrights are owned by their respective owners.